These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 22331427)

  • 1. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
    Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
    Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
    Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
    PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin.
    Ndam NT; Denoeud-Ndam L; Doritchamou J; Viwami F; Salanti A; Nielsen MA; Fievet N; Massougbodji A; Luty AJ; Deloron P
    Emerg Infect Dis; 2015 May; 21(5):813-23. PubMed ID: 25898123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
    Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
    J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon.
    Lloyd YM; Fang R; Bobbili N; Vanda K; Ngati E; Sanchez-Quintero MJ; Salanti A; Chen JJ; Leke RGF; Taylor DW
    Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29986889
    [No Abstract]   [Full Text] [Related]  

  • 6. Chondroitin sulphate A (CSA)-binding of single recombinant Duffy-binding-like domains is not restricted to Plasmodium falciparum Erythrocyte Membrane Protein 1 expressed by CSA-binding parasites.
    Resende M; Ditlev SB; Nielsen MA; Bodevin S; Bruun S; Pinto VV; Clausen H; Turner L; Theander TG; Salanti A; Dahlbäck M
    Int J Parasitol; 2009 Sep; 39(11):1195-204. PubMed ID: 19324047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women.
    Taylor DW; Zhou A; Marsillio LE; Thuita LW; Leke EB; Branch O; Gowda DC; Long C; Leke RF
    Infect Immun; 2004 Mar; 72(3):1603-7. PubMed ID: 14977967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Development, Fine Specificity, and Importance of High-Avidity Antibodies to VAR2CSA in Pregnant Cameroonian Women Living in Yaoundé, an Urban City.
    Vanda K; Bobbili N; Matsunaga M; Chen JJ; Salanti A; Leke RFG; Taylor DW
    Front Immunol; 2021; 12():610108. PubMed ID: 33717094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
    Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
    Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.
    Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE
    Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1.
    Barfod L; Dalgaard MB; Pleman ST; Ofori MF; Pleass RJ; Hviid L
    Proc Natl Acad Sci U S A; 2011 Jul; 108(30):12485-90. PubMed ID: 21746929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VAR2CSA signatures of high Plasmodium falciparum parasitemia in the placenta.
    Rovira-Vallbona E; Monteiro I; Bardají A; Serra-Casas E; Neafsey DE; Quelhas D; Valim C; Alonso P; Dobaño C; Ordi J; Menéndez C; Mayor A
    PLoS One; 2013; 8(7):e69753. PubMed ID: 23936092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
    Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
    PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing a VAR2CSA-based vaccine to prevent placental malaria.
    Fried M; Duffy PE
    Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens.
    Siriwardhana C; Fang R; Salanti A; Leke RGF; Bobbili N; Taylor DW; Chen JJ
    Malar J; 2017 Sep; 16(1):391. PubMed ID: 28962616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural insights into chondroitin sulphate A binding Duffy-binding-like domains from Plasmodium falciparum: implications for intervention strategies against placental malaria.
    Gill J; Chitnis CE; Sharma A
    Malar J; 2009 Apr; 8():67. PubMed ID: 19374733
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Tornyigah B; d'Almeida T; Escriou G; Viwami F; Fievet N; Luty AJF; Massougbodji A; Nielsen MA; Deloron P; Tuikue Ndam N
    Front Immunol; 2021; 12():610305. PubMed ID: 33968015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
    Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
    J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant Women.
    McLean ARD; Opi DH; Stanisic DI; Cutts JC; Feng G; Ura A; Mueller I; Rogerson SJ; Beeson JG; Fowkes FJI
    Front Immunol; 2021; 12():644563. PubMed ID: 34220804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
    Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
    Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.